The Journal of Organic Chemistry
Note
2H), 2.08−2.00 (m, 2H), 1.94−1.87 (m, 2H), 1.33−1.25 (m, 12H),
0.90−0.84 (m, 6H). 13C{1H} NMR (101 MHz, CDCl3) δ 141.9,
135.5, 133.8, 126.8, 50.1, 48.8, 31.4, 31.3, 30.1, 30.0, 26.3, 26.2, 22.6,
20.5, 19.6, 14.1, 14.1. HRMS (ESI-HRMS) (m/z): Calcd for
C18H31N6, (M+H)+: 331.2605; found: 331.2605.
1H), 7.09−7.07 (m, 1H), 7.00−6.98 (m, 1H), 6.93−6.91 (m, 1H),
6.02 (s, 2H), 5.70 (s, 2H), 3.17−3.13 (m, 2H), 3.01−2.97 (m, 2H).
13C{1H} NMR (101 MHz, CDCl3) δ 142.1, 136.9, 135.8, 134.1,
128.6, 127.9, 127.5, 127.2, 127.1, 126.9, 47.7, 47.4, 20.3, 19.6. HRMS
(ESI-HRMS) (m/z): Calcd for C16H15N6S2,(M+H)+: 355.0794;
found: 355.0794
2,2′-(4,5-Dihydrobenzo[1,2-d:3,4-d′]bis([1,2,3]triazole)-1,6-diyl)-
diethanol (4g). The reaction was performed according to procedure
B with triazoloketone 1a (52 mg, 0.2 mmol), 2-aminoethanol 2g (31
mg, 0.50 mmol), and 4-nitrophenylazide 3 (39 mg, 0.24 mmol). The
crude reaction mixture was then directly purified by silica gel column
chromatography (CH2Cl2 followed by petroleum ether/EtOAc = 2:8)
to afford the product 4g as a colorless viscous liquid (40 mg, 81%).
Analytical data of 4g: 1H NMR (400 MHz, MeOD) δ 4.78 (t, J = 5.6
Hz, 2H), 4.49 (t, J = 4.8 Hz, 2H), 4.09 (t, J = 5.6 Hz, 2H), 3.96 (t, J =
4.8 Hz, 2H), 3.25−3.21 (m, 2H), 3.18−3.14 (m, 2H). 13C{1H} NMR
(101 MHz, MeOD) δ 143.6, 137.8, 135.7, 128.8, 61.9, 61.3, 53.3,
52.3, 20.9, 20.5. HRMS (ESI-HRMS) (m/z): Calcd for C10H15N6O2,
(M+H)+: 251.1251; Found: 251.1256.
1,6-Bis(2-(1H-indol-3-yl)ethyl)-1,4,5,6-tetrahydrobenzo[1,2-
d:3,4-d′]bis([1,2,3]triazole) (4l). The reaction was performed
according to procedure B with triazoloketone 1a (52 mg, 0.2
mmol), 2-(1H-indol-3-yl)ethanamine 2l (80 mg, 0.50 mmol), and 4-
nitrophenylazide 3 (39 mg, 0.24 mmol). The crude reaction mixture
was then directly purified by silica gel column chromatography
(CH2Cl2 followed by petroleum ether/EtOAc = 1:4) to afford the
product 4l as a white semisolid (54 mg, 60%). Analytical data of 4l:
1H NMR (300 MHz, CDCl3) δ 8.09−8.07 (m, 2H), 7.66 (d, J = 7.5
Hz, 1H), 7.40−7.28 (m, 3H), 7.20−7.04 (m, 5H), 6.71 (d, J = 2.0 Hz,
1H), 4.97 (t, J = 7.6 Hz, 2H), 4.55 (t, J = 6.5 Hz, 2H), 3.50 (t, J = 7.5
Hz, 2H), 3.36 (t, J = 6.4 Hz, 2H), 2.62 (t, J = 8.1 Hz, 2H), 2.15 (t, J =
8.1 Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3) δ 142.1, 142.1,
136.3, 136.2, 135.1, 134.8, 127.6, 127.0, 126.9, 122.8, 122.7, 122.1,
120.0, 119.7, 111.7, 111.6, 111.2, 111.1, 50.6, 49.5, 26.7, 26.3, 20.1,
19.1. HRMS (ESI-HRMS) (m/z): Calcd for C26H25N8, (M+H)+:
449.2197; found: 449.2193.
1,6-Dihexyl-4-methyl-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-d′]bis-
([1,2,3]triazole) (4m). The reaction was performed according to
procedure B with triazoloketone 1b (54 mg, 0.2 mmol), n-hexylamine
2f (51 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39 mg, 0.24
mmol). The crude reaction mixture was then directly purified by silica
gel column chromatography (CH2Cl2 followed by petroleum ether/
EtOAc = 3:7) to afford the product 4m as a colorless viscous liquid
(54 mg, 78%). Analytical data of 4m: 1H NMR (400 MHz, CDCl3) δ
4.67 (t, J = 7.2 Hz, 2H), 4.35−4.27 (m, 2H), 3.52−3.42 (m, 1H),
3.15 (dd, J1 = 16.4 Hz, J2 = 7.6 Hz, 1H), 2.70 (dd, J1 = 16.4, J2 = 8.4
Hz, 1H), 2.07−2.00 (m, 2H), 1.91−1.86 (m, 2H), 1.47 (d, J = 6.8 Hz,
3H), 1.35−1.28 (m, 12H), 0.89−0.83 (m, 6H). 13C{1H} NMR (101
MHz, CDCl3) δ 146.4, 135.2, 133.6, 125.9, 50.0, 48.8, 31.3, 30.1, 28.3,
27.9, 26.2, 22.6, 19.8, 14.1. HRMS (ESI-HRMS) (m/z): Calcd for
C19H33N6, (M+H)+: 345.2761; found: 345.2761.
1,6-Bis(4-methoxyphenyl)-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-d′]-
bis([1,2,3]triazole) (4h). The reaction was performed according to
procedure B with triazoloketone 1a (52 mg, 0.2 mmol), 4-methoxy
aniline 2h (62 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39 mg,
0.24 mmol). The crude reaction mixture was then directly purified by
silica gel column chromatography (CH2Cl2 followed by petroleum
ether/EtOAc = 2:8) to afford the product 4h as a white solid (56 mg,
1
75%). mp: 182−184 °C. Analytical data of 4h: H NMR (400 MHz,
CDCl3) δ 8.00 (d, J = 9.2 Hz, 2H), 7.46−7.44 (m,2H), 7.10−7.05 (m,
4H), 3.89 (s, 6H), 3.30−3.25 (m, 2H), 3.19−3.15 (m, 2H). 13C{1H}
NMR (101 MHz, CDCl3) δ 160.6, 160.2, 143.0, 135.9, 134.8, 130.2,
129.1, 125.3, 124.9, 115.0, 114.6, 55.8, 55.7, 20.9, 20.5. HRMS (ESI-
HRMS) (m/z): Calcd for C20H19N6O2, (M+H)+: 375.1564; found:
375.1567.
1,6-Diallyl-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-d′]bis([1,2,3]-
triazole) (4i). The reaction was performed according to procedure B
with triazoloketone 1a (52 mg, 0.2 mmol), allylamine 2i (26 mg, 0.50
mmol), and 4-nitrophenylazide 3 (39 mg, 0.24 mmol). The crude
reaction mixture was then directly purified by silica gel column
chromatography (CH2Cl2 followed by petroleum ether/EtOAc = 2:8)
to afford the product 4i as a brown viscous liquid (33 mg, 68%).
1
1,6-Dihexyl-4-phenyl-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-d′]bis-
([1,2,3]triazole) (4n). The reaction was performed according to
procedure B with triazoloketone 1c (67 mg, 0.2 mmol), n-hexylamine
2f (51 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39 mg, 0.24
mmol). The crude reaction mixture was then directly purified by silica
gel column chromatography (CH2Cl2 followed by petroleum ether/
EtOAc = 3:7) to afford the product 4n as a brown viscous liquid (61
Analytical data of 4i: H NMR (400 MHz, CDCl3) δ 6.20−6.10 (m,
1H), 6.03−5.93 (m, 1H), 5.40−5.33 (m, 2H), 5.34−5.28 (m, 3H),
5.24−5.18 (m, 1H), 4.99−4.97 (m, 2H), 3.21 (t, J = 7.6 Hz, 2H),
3.05 (t, J = 8.8 Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3) δ 142.1,
135.7, 134.4, 131.5, 130.8, 126.8, 119.8, 52.1, 51.3, 20.4, 19.5. HRMS
(ESI-HRMS) (m/z): Calcd for C12H15N6, (M+H)+: 243.1353;
Found: 243.1350.
1
mg, 75%). Analytical data of 4n: H NMR (300 MHz, CDCl3) δ
1,6-Bis(pyridin-2-ylmethyl)-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-
d′]bis([1,2,3]triazole) (4j). The reaction was performed according to
procedure B with triazoloketone 1a (52 mg, 0.2 mmol), pyridin-2-
ylmethanamine 2j (54 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39
mg, 0.24 mmol). The crude reaction mixture was then directly
purified by silica gel column chromatography (CH2Cl2 followed by
petroleum ether/EtOAc = 1:9) to afford the product 4j as a brown
7.30−7.23 (m, 4H), 7.16−7.13 (m, 2H), 4.74 (t, J = 7.5 Hz, 2H),
4.68−4.63 (m, 1H), 4.26 (t, J = 6.9 Hz, 2H), 3.48−3.40 (m, 1H),
3.19−3.11 (m, 1H), 2.11−2.04 (m, 2H), 1.84−1.75 (m, 2H), 1.39−
1.24 (m, 12H), 0.89−0.85 (m, 6H). 13C{1H} NMR (101 MHz,
CDCl3) δ 144.4, 142.0, 135.3, 133.1, 129.0, 127.5, 127.4, 50.2, 48.9,
38.7, 31.3, 31.2, 30.1, 30.0, 29.6, 26.3, 26.2, 22.6, 22.5, 14.1. HRMS
(ESI-HRMS) (m/z): Calcd for C24H35N6, (M+H)+: 407.2918; found:
407.2915.
1
viscous liquid (45 mg, 65%). Analytical data of 4j: H NMR (400
MHz, CDCl3) δ 8.58−8.55 (m, 2H), 7.69−7.67 (m, 1H), 7.62−7.60
(m, 2H), 7.28−7.24 (m, 2H), 7.21−7.18 (m, 2H), 6.02 (s, 2H), 5.62
(s, 2H), 3.22−3.18 (m, 2H), 3.11−3.06 (m, 2H). 13C{1H} NMR
(101 MHz, CDCl3) δ 154.8, 154.0, 149.9, 149.9, 142.2, 137.5, 137.1,
135.7, 135.2, 127.4, 123.6, 123.1, 122.4, 122.3, 54.7, 54.2, 20.3, 19.7.
HRMS (ESI-HRMS) (m/z): Calcd for C18H17N8, (M+H)+:
345.1571; Found: 345.1580.
1,6-Dihexyl-4,4-dimethyl-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-d′]-
bis([1,2,3]triazole) (4o). The reaction was performed according to
procedure B with triazoloketone 1d (58 mg, 0.2 mmol), 4-methoxy
benzylamine 2a (69 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39
mg, 0.24 mmol). The crude reaction mixture was then directly
purified by silica gel column chromatography (CH2Cl2 followed by
petroleum ether/EtOAc = 3:7) to afford the product 4o as a white
1,6-Bis(thiophen-2-ylmethyl)-1,4,5,6-tetrahydrobenzo[1,2-d:3,4-
d′]bis([1,2,3]triazole)(4k). The reaction was performed according to
procedure B with triazoloketone 1a (52 mg, 0.2 mmol), thiophen-2-
ylmethanamine 2k (57 mg, 0.50 mmol), and 4-nitrophenylazide 3 (39
mg, 0.24 mmol). The crude reaction mixture was then directly
purified by silica gel column chromatography (CH2Cl2 followed by
petroleum ether/EtOAc = 1:9) to afford the product 4k as a brown
1
semisolid (72 mg, 84%). Analytical data of 4o: H NMR (400 MHz,
CDCl3) δ 7.53 (d, J = 8.8 Hz, 2H), 7.15 (d, J = 8.8 Hz, 2H), 6.84 (dd,
J1 = 16.6, J2 = 8.8 Hz, 4H), 5.78 (s, 2H), 5.46 (s, 2H), 3.78 (s, 3H),
3.74 (s, 3H), 2.64 (s, 2H), 1.29 (s, 6H). 13C{1H} NMR (101 MHz,
CDCl3) δ 159.9, 159.7, 150.1, 135.4, 133.9, 130.4, 129.1, 127.5, 126.2,
124.5, 114.6, 114.1, 55.4, 55.3, 52.8, 52.3, 35.5, 33.6, 28.1. HRMS
(ESI-HRMS) (m/z): Calcd for C24H27N6O2, (M+H)+: 431.2190;
found: 431.2189.
1
semisolid (51 mg, 72%). Analytical data of 4j: H NMR (400 MHz,
CDCl3) δ 7.36−7.35 (m, 1H), 7.32−7.30 (m, 1H), 7.24−7.23 (m,
4351
J. Org. Chem. 2021, 86, 4346−4354